Vladimir V. Novikov
Research Subjects
Vladimir V. Novikov has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Boris Yurievich Volodin
Ryazan State Medical University
8 shared publications - Ilya Andreevich Fedotov
Рязанский государственный медицинский университет имени академика И.П. Павлова
5 shared publications - Dmitriy I. Shustov
Ryazan State Medical University, Ryazan, Russia
4 shared publications - Aleksey Vladimirovich Merinov
Ryazan State Med Univ, Ryazan, Russia
3 shared publications - Dmitry Sergeevich Petrov
Ryazan State Medical University
3 shared publications - Egor V. Leonov
Ryazan State Medical University
2 shared publications
Latest Publications
- 30 September 2026
- Published by ECO-Vector LLC (Publications) in I.P. Pavlov Russian Medical Biological Herald
- Vol. 34 (3) , 335-346
Initial results of search for neuropsychological markers of the schizophrenia endophenotype in patients with synthetic cathinone-induced psychotic disorders: a cross-sectional study
BACKGROUND: The rising incidence of psychotic disorders (PDs) induced by synthetic cathinones (SCs) underscores the relevance of search for markers for differentiating this pathology from schizophrenia spectrum psychoses. AIM: To investigate neuropsychological markers of the schizophrenia endophenotype in patients with SC-induced psychotic disorders (SCIPD) and evaluate a possibility of their use in differential diagnosis. METHODS: This observational, cross-sectional, randomized study was conducted from September 2023 to December 2025. Participants were allocated into four groups: Group 1 (healthy controls, n=32); Group 2 (patients with psychostimulant dependence syndrome (PSDS), n=31)), Group 3 (patients with SCIPD, n=30), Group 4 (patients with schizophrenia, n=30). Neuropsychological markers of the schizophrenia endophenotype, selected based on data of meta-analyses, were evaluated using the following instruments: the Continuous Performance Test–Identical Pairs (CPT-IP; DPrime, and False Alarm Catch Rate parameters), the Trail Making Test (parameter Trail B Time and Trail B–Trail A Time difference score), the Stroop test (processing speed and accuracy/inhibition indices), and the Edinburgh Handedness Inventory–Laterality Quotient (EHI-LQ; dominant lateralization index). All tests were performed in the Inquisit computerized environment (Millisecond Inc., USA). RESULTS: The control group performed significantly better than all clinical groups on the DPrime (CPT-IP) and Trail B Time parameters. Group 3 did not differ from Group 4 in the main neurocognitive parameters, with the exception of a higher False Alarm Catch Rate (CPT-IP) and a more pronounced tendency to left-handedness (EHI-LQ). Between-group comparison across the full marker profile revealed significant differences between controls and all clinical groups, as well as between Groups 2 and 4 (p 0.05). Patients in Group 3 occupied an intermediate position between Groups 2 and 4, not differing significantly from them. CONCLUSION: TThe selected neuropsychological markers of schizophrenia endophenotype, primarily reflecting functioning of the dorsolateral prefrontal cortex, do not differentiate SCIPD from schizophrenia. The deficits of sustained attention and cognitive flexibility identified in patients with SCIPD, indistinguishable from those in schizophrenia, suggest hypofrontality and may point to premorbid vulnerability or dopamine sensitization as a mechanism of transformation into schizophrenia. The increased prevalence of left-handedness in the SCIPD group supports the hypothesis of the presence of a pre-existing schizophrenia endophenotype prior to the onset of substance use.
- 30 September 2026
- Published by ECO-Vector LLC (Publications) in I.P. Pavlov Russian Medical Biological Herald
- Vol. 34 (3) , 335-346
Initial results of search for neuropsychological markers of the schizophrenia endophenotype in patients with synthetic cathinone-induced psychotic disorders: a cross-sectional study
BACKGROUND: The rising incidence of psychotic disorders (PDs) induced by synthetic cathinones (SCs) underscores the relevance of search for markers for differentiating this pathology from schizophrenia spectrum psychoses. AIM: To investigate neuropsychological markers of the schizophrenia endophenotype in patients with SC-induced psychotic disorders (SCIPD) and evaluate a possibility of their use in differential diagnosis. METHODS: This observational, cross-sectional, randomized study was conducted from September 2023 to December 2025. Participants were allocated into four groups: Group 1 (healthy controls, n=32); Group 2 (patients with psychostimulant dependence syndrome (PSDS), n=31)), Group 3 (patients with SCIPD, n=30), Group 4 (patients with schizophrenia, n=30). Neuropsychological markers of the schizophrenia endophenotype, selected based on data of meta-analyses, were evaluated using the following instruments: the Continuous Performance Test–Identical Pairs (CPT-IP; DPrime, and False Alarm Catch Rate parameters), the Trail Making Test (parameter Trail B Time and Trail B–Trail A Time difference score), the Stroop test (processing speed and accuracy/inhibition indices), and the Edinburgh Handedness Inventory–Laterality Quotient (EHI-LQ; dominant lateralization index). All tests were performed in the Inquisit computerized environment (Millisecond Inc., USA). RESULTS: The control group performed significantly better than all clinical groups on the DPrime (CPT-IP) and Trail B Time parameters. Group 3 did not differ from Group 4 in the main neurocognitive parameters, with the exception of a higher False Alarm Catch Rate (CPT-IP) and a more pronounced tendency to left-handedness (EHI-LQ). Between-group comparison across the full marker profile revealed significant differences between controls and all clinical groups, as well as between Groups 2 and 4 (p 0.05). Patients in Group 3 occupied an intermediate position between Groups 2 and 4, not differing significantly from them. CONCLUSION: TThe selected neuropsychological markers of schizophrenia endophenotype, primarily reflecting functioning of the dorsolateral prefrontal cortex, do not differentiate SCIPD from schizophrenia. The deficits of sustained attention and cognitive flexibility identified in patients with SCIPD, indistinguishable from those in schizophrenia, suggest hypofrontality and may point to premorbid vulnerability or dopamine sensitization as a mechanism of transformation into schizophrenia. The increased prevalence of left-handedness in the SCIPD group supports the hypothesis of the presence of a pre-existing schizophrenia endophenotype prior to the onset of substance use.
- 31 March 2026
- Published by Ryazan State Medical University in Nauka Molodykh (Eruditio Juvenium)
- Vol. 14 (1)
Borderline Personality Disorder and Borderline Character Accentuation: a Comparison of Suicidal Characteristics in Women
BACKGROUND: Borderline personality disorder (BPD) currently remains an important topic in psychiatric research due to significant prevalence of self-injurious behavior in individuals with this disorder. However, differences in the suicidal behavior between patients with BPD and those exhibiting only specific borderline personality traits (BPT) — character accentuation are understudied. AIM: To identify and describe differences in suicidal behavior characteristics between patients with BPD and BPT for development of personalized prevention programs. METHODS: This observational cross-sectional study involved 120 female patients with a history of self-injurious behavior undergoing inpatient treatment in Bazhenov Ryazan Regional Clinical Psychiatric Hospital. For assessment, adapted specialized clinical and psychometric scales were used. RESULTS: Patients with BPD demonstrated more pronounced emotional dysregulation (p <0.0001), cognitive impairment (p <0.0001), impulsive behavior (p<0.0001), and dysfunction in interpersonal relationships (p <0.001). In addition, they showed more significant results for negative affects (p <0.0001), detachment (p=0.0001), antagonism (p=0.0009), disinhibition (p <0.0001), psychoticism (p <0.0001), anxiety (p <0.0001), and depression (p <0.0001) among the personality patterns in the ‘Personality Inventory for DSM-5 — Brief Form’ (PID5BF). Patients with BPD had statistically significant differences in the following suicide risk factors: emotionality (p <0.0001), incompetence (p <0.0001), pessimism (p <0.0001), decreased time perspective (p <0.0001), demonstrativeness (p <0.0001), and uniqueness (p <0.0001). In addition, they expressed fear of being forgotten after death (p=0.0112). The BPT group had a statistically significantly higher score in the anti-suicide index (p=0.0076). According to the Mini-SMIL results, the BPT group had significantly higher scores on the ‘Denial of Anxiety and Hypomanic Tendencies’ scale (p=0.0001). Patients with BPD showed significantly higher results on the following scales: ‘Somatic anxiety’ (p=0.0084), ‘Anxiety and depressive tendencies’ (p=0.0009), ‘Repression of factors causing anxiety’ (p=0.0224), ‘Realization of emotional orientation in direct behavior, impulsiveness’ (p=0.0002), ‘Fixation of anxiety and restrictive behavior’ (p=0.0005) and the autism scale (p=0.0006). CONCLUSION: The study results showed that self-harming behavior in female patients with BPD and those with BPT had different characteristics, which is important to take into account in prevention programs.
- 31 March 2026
- Published by Ryazan State Medical University in Nauka Molodykh (Eruditio Juvenium)
- Vol. 14 (1)
Borderline Personality Disorder and Borderline Character Accentuation: a Comparison of Suicidal Characteristics in Women
BACKGROUND: Borderline personality disorder (BPD) currently remains an important topic in psychiatric research due to significant prevalence of self-injurious behavior in individuals with this disorder. However, differences in the suicidal behavior between patients with BPD and those exhibiting only specific borderline personality traits (BPT) — character accentuation are understudied. AIM: To identify and describe differences in suicidal behavior characteristics between patients with BPD and BPT for development of personalized prevention programs. METHODS: This observational cross-sectional study involved 120 female patients with a history of self-injurious behavior undergoing inpatient treatment in Bazhenov Ryazan Regional Clinical Psychiatric Hospital. For assessment, adapted specialized clinical and psychometric scales were used. RESULTS: Patients with BPD demonstrated more pronounced emotional dysregulation (p <0.0001), cognitive impairment (p <0.0001), impulsive behavior (p<0.0001), and dysfunction in interpersonal relationships (p <0.001). In addition, they showed more significant results for negative affects (p <0.0001), detachment (p=0.0001), antagonism (p=0.0009), disinhibition (p <0.0001), psychoticism (p <0.0001), anxiety (p <0.0001), and depression (p <0.0001) among the personality patterns in the ‘Personality Inventory for DSM-5 — Brief Form’ (PID5BF). Patients with BPD had statistically significant differences in the following suicide risk factors: emotionality (p <0.0001), incompetence (p <0.0001), pessimism (p <0.0001), decreased time perspective (p <0.0001), demonstrativeness (p <0.0001), and uniqueness (p <0.0001). In addition, they expressed fear of being forgotten after death (p=0.0112). The BPT group had a statistically significantly higher score in the anti-suicide index (p=0.0076). According to the Mini-SMIL results, the BPT group had significantly higher scores on the ‘Denial of Anxiety and Hypomanic Tendencies’ scale (p=0.0001). Patients with BPD showed significantly higher results on the following scales: ‘Somatic anxiety’ (p=0.0084), ‘Anxiety and depressive tendencies’ (p=0.0009), ‘Repression of factors causing anxiety’ (p=0.0224), ‘Realization of emotional orientation in direct behavior, impulsiveness’ (p=0.0002), ‘Fixation of anxiety and restrictive behavior’ (p=0.0005) and the autism scale (p=0.0006). CONCLUSION: The study results showed that self-harming behavior in female patients with BPD and those with BPT had different characteristics, which is important to take into account in prevention programs.
- Open Access
- 2 July 2025
- Published by ECO-Vector LLC in I.P. Pavlov Russian Medical Biological Herald
- Vol. 33 (2) , 251-258
Narcological Characteristics of Young Women with Bulimia Nervosa
INTRODUCTION: Eating disorders are one most common mental disorder. In this article, we address the topic of comorbid conditions in young women as part of narcological practice. AIM: To conduct a comprehensive study of narcological characteristics of young women with bulimia nervosa. MATERIALS AND METHODS: A total of 195 young women aged 20–27 years were examined. The study group included 40 women with bulimia nervosa, the control group included women (n=155) without this diagnosis. The following diagnostic tools were used: a clinical and anamnestic questionnaire aimed at identifying patterns of autoaggressive behavior (including questions on detecting the use of psychoactive substances), the RUS-AUDIT test (Alcohol Use Disorders Identification Test); the M.I.N.I. (Mini-International Neuropsychiatric Interview) short international neuropsychiatric questionnaire. RESULTS: When comparing the study and control groups, statistically significant results were found concerning the criteria of hazardous use of alcohol and alcohol dependence syndrome (RUS-AUDIT) in the study group, which is confirmed by the data of the section ‘current alcohol dependence’ of the M.I.N.I. short neuropsychiatric questionnaire (р 0.05 in all cases). Tobacco smoking and a tendency to its increase over the past 2 years statistically significantly predominated in the study group (almost 4 times). Analysis of self-reports in terms of subjectively excessive consumption of alcoholic drinks revealed both low control over alcohol consumption, and a low level of subjective assessment of the existence of problems with alcohol consumption. CONCLUSION: Eating disorders (in this study, bulimia nervosa) are largely associated with various drug addiction problems, primarily with disorders related to alcohol abuse. The data obtained expand the current knowledge of comorbidity of bulimia nervosa with drug spectrum disorders, which permits to create more personalized therapeutic and preventive programs.
- 2 July 2025
- Published by ECO-Vector LLC in I.P. Pavlov Russian Medical Biological Herald
- Vol. 33 (2) , 251-258
Open AccessNarcological Characteristics of Young Women with Bulimia Nervosa
INTRODUCTION: Eating disorders are one most common mental disorder. In this article, we address the topic of comorbid conditions in young women as part of narcological practice. AIM: To conduct a comprehensive study of narcological characteristics of young women with bulimia nervosa. MATERIALS AND METHODS: A total of 195 young women aged 20–27 years were examined. The study group included 40 women with bulimia nervosa, the control group included women (n=155) without this diagnosis. The following diagnostic tools were used: a clinical and anamnestic questionnaire aimed at identifying patterns of autoaggressive behavior (including questions on detecting the use of psychoactive substances), the RUS-AUDIT test (Alcohol Use Disorders Identification Test); the M.I.N.I. (Mini-International Neuropsychiatric Interview) short international neuropsychiatric questionnaire. RESULTS: When comparing the study and control groups, statistically significant results were found concerning the criteria of hazardous use of alcohol and alcohol dependence syndrome (RUS-AUDIT) in the study group, which is confirmed by the data of the section ‘current alcohol dependence’ of the M.I.N.I. short neuropsychiatric questionnaire (р 0.05 in all cases). Tobacco smoking and a tendency to its increase over the past 2 years statistically significantly predominated in the study group (almost 4 times). Analysis of self-reports in terms of subjectively excessive consumption of alcoholic drinks revealed both low control over alcohol consumption, and a low level of subjective assessment of the existence of problems with alcohol consumption. CONCLUSION: Eating disorders (in this study, bulimia nervosa) are largely associated with various drug addiction problems, primarily with disorders related to alcohol abuse. The data obtained expand the current knowledge of comorbidity of bulimia nervosa with drug spectrum disorders, which permits to create more personalized therapeutic and preventive programs.
- 28 April 2025
- Published by PANORAMA Publishing House in Vestnik Nevrologii, Psihiatrii i Nejrohirurgii (Bulletin of Neurology, Psychiatry and Neurosurgery)
- No. 5,p. 601-611
The role of interdepartmental cooperation in the medical rehabilitation of patients with drug-related disorders (using the example of the experience of the Department of inpatient medical and psychological rehabilitation Ryazan regional clinical narcological dispensary)
The article highlights the current issue of medical rehabilitation of patients with drug-related disorders (HP). The article considers the role of interdepartmental cooperation in providing medical and social assistance to drug treatment patients of the rehabilitation narcological department in cooperation with government agencies providing social services, as well as with representatives of the Russian Orthodox Church. The results of the evaluation of the work of the department of inpatient medical and psychological rehabilitation of the State Budgetary Institution of the Ryazan region «Regional Clinical Narcological Dispensary» using the principle of interdepartmental interaction are presented. The organizational model used has a positive effect on the duration of remission of the rehabilitated, the quality of their life, and the formation of the biopsychosociospiritual sphere of the narcological patient. The multiprofessional approach has a positive effect on the socialization of this category of patients. The paper presents recommendations on the organization of interdepartmental cooperation at the level of inpatient care. Attention is drawn to the need to ensure continuous, consistent and continuous provision of medical, social and spiritual support to the patient.
- 28 April 2025
- Published by PANORAMA Publishing House in Vestnik Nevrologii, Psihiatrii i Nejrohirurgii (Bulletin of Neurology, Psychiatry and Neurosurgery)
- No. 5,p. 601-611
The role of interdepartmental cooperation in the medical rehabilitation of patients with drug-related disorders (using the example of the experience of the Department of inpatient medical and psychological rehabilitation Ryazan regional clinical narcological dispensary)
The article highlights the current issue of medical rehabilitation of patients with drug-related disorders (HP). The article considers the role of interdepartmental cooperation in providing medical and social assistance to drug treatment patients of the rehabilitation narcological department in cooperation with government agencies providing social services, as well as with representatives of the Russian Orthodox Church. The results of the evaluation of the work of the department of inpatient medical and psychological rehabilitation of the State Budgetary Institution of the Ryazan region «Regional Clinical Narcological Dispensary» using the principle of interdepartmental interaction are presented. The organizational model used has a positive effect on the duration of remission of the rehabilitated, the quality of their life, and the formation of the biopsychosociospiritual sphere of the narcological patient. The multiprofessional approach has a positive effect on the socialization of this category of patients. The paper presents recommendations on the organization of interdepartmental cooperation at the level of inpatient care. Attention is drawn to the need to ensure continuous, consistent and continuous provision of medical, social and spiritual support to the patient.
- 12 October 2023
- Published by ECO-Vector LLC in I.P. Pavlov Russian Medical Biological Herald
- Vol. 31 (3) , 467-479
Peculiarities of Clinical Symptoms, Somatic Complications, Approaches to Therapy and Outcomes of Delirium Induced by Exposure to Synthetic Cannabinoids: Systematic Review
INTRODUCTION: The use of synthetic cannabinoids (SCs) is an urgent healthcare problem, due to, among other things, a high number of complications. AIM: To systematize the peculiarities of clinical presentation, somatic complications, effectiveness of empirical approaches to therapy, and probable outcomes of delirium induced by exposure to SCs. MATERIALS AND METHODS: The analysis of scientific publications selected by the keywords in eLibrary, СNKI, PubMed databases, was conducted. According to PRISMA recommendations, 20 articles were taken for analysis. RESULTS: Today, it is impossible to predict the period when SC-induced delirium may occur. It can start after one-time intake of even small dose, and can occur both due to intoxication and with the underlying withdrawal state on the 2nd4th days after the last use. Besides classic symptoms, the clinical picture of delirium is characterized by many symptoms of schizophrenic psychoses: hallucinations of threatening or drug-addicted content; secondary paranoid delusion, less expressed than hallucinations; aggressiveness and agitated behavior; some formal thinking disorders; rarely, KandinskiClerambault and oneiroid syndromes. There are reported cases of severe somatic complications in the form of depression of consciousness, rhabdomyolysis, acute renal failure, cardiomyopathy, myocardial infarction, epilepsy, infectious complications with the underlying weakened immunity. Therapy of SC-induced delirium includes detoxification and metabolic therapy, administration of antipsychotics and tranquilizers; use of resuscitation measures in case of depression of consciousness and development of life-threatening conditions. SC-induced delirium lasts from several hours to several days. In most cases, it terminates with complete recovery with amnesia of the period of confusion and asthenia, but in some cases fatal outcomes are reported caused not only by accidents such as road accidents or suicide, but also by somatic complications (most often of infectious character, or multi-organ failure). CONCLUSION: SСs remain relevant due to high frequency of their use and continuous emergence of new analogs to substances of this group. They have multidirectional effect, and so far it is difficult to predict at what period the delirium induced by them may occur.
- 12 October 2023
- Published by ECO-Vector LLC in I.P. Pavlov Russian Medical Biological Herald
- Vol. 31 (3) , 467-479
Peculiarities of Clinical Symptoms, Somatic Complications, Approaches to Therapy and Outcomes of Delirium Induced by Exposure to Synthetic Cannabinoids: Systematic Review
INTRODUCTION: The use of synthetic cannabinoids (SCs) is an urgent healthcare problem, due to, among other things, a high number of complications. AIM: To systematize the peculiarities of clinical presentation, somatic complications, effectiveness of empirical approaches to therapy, and probable outcomes of delirium induced by exposure to SCs. MATERIALS AND METHODS: The analysis of scientific publications selected by the keywords in eLibrary, СNKI, PubMed databases, was conducted. According to PRISMA recommendations, 20 articles were taken for analysis. RESULTS: Today, it is impossible to predict the period when SC-induced delirium may occur. It can start after one-time intake of even small dose, and can occur both due to intoxication and with the underlying withdrawal state on the 2nd4th days after the last use. Besides classic symptoms, the clinical picture of delirium is characterized by many symptoms of schizophrenic psychoses: hallucinations of threatening or drug-addicted content; secondary paranoid delusion, less expressed than hallucinations; aggressiveness and agitated behavior; some formal thinking disorders; rarely, KandinskiClerambault and oneiroid syndromes. There are reported cases of severe somatic complications in the form of depression of consciousness, rhabdomyolysis, acute renal failure, cardiomyopathy, myocardial infarction, epilepsy, infectious complications with the underlying weakened immunity. Therapy of SC-induced delirium includes detoxification and metabolic therapy, administration of antipsychotics and tranquilizers; use of resuscitation measures in case of depression of consciousness and development of life-threatening conditions. SC-induced delirium lasts from several hours to several days. In most cases, it terminates with complete recovery with amnesia of the period of confusion and asthenia, but in some cases fatal outcomes are reported caused not only by accidents such as road accidents or suicide, but also by somatic complications (most often of infectious character, or multi-organ failure). CONCLUSION: SСs remain relevant due to high frequency of their use and continuous emergence of new analogs to substances of this group. They have multidirectional effect, and so far it is difficult to predict at what period the delirium induced by them may occur.
- 30 June 2023
- Published by Ryazan State Medical University in Nauka Molodykh (Eruditio Juvenium)
- Vol. 11 (2)
Analysis of Symptoms, Approaches to Therapy and Outcomes of Synthetic Cathinone-Induced Delirium: Systematic Review
INTRODUCTION: One of the important disorders that can be induced by using synthetic cathinones (SC) is delirium, differentiated from other psychotic complications in ICD-11. The article presents a systematic review of the literature with the aim to describe the symptoms, the effectiveness of empirical approaches to therapy and probable outcomes of delirium induced by SC. The analysis of scientific publications in eLibrary, CNKI, PubMed, Scopus databases was performed using search by keywords. In accordance with the recommendations of PRISMA, 23 articles were selected. CONCLUSION: Most of the articles found were about MDPV-induced delirium. No exact dose range of SC that can cause delirium is specified. Delirium is more often described after prolonged use of SC (for 1 month), in more rare cases after a single use. In most cases delirium develops within a few hours after intake of SC and is associated with intoxication, rather than with withdrawal syndrome. The clinical picture of the studied conditions, besides the triad of the main symptoms of delirium, includes psychomotor excitement with pronounced sympathicotonia, in the vast majority of cases psychotic symptoms (acute sensory delirium with paranoid syndrome, true visual hallucinations, insomnia, aggressiveness expressed in the form of hetero- or autoaggression) are also present. Of highest effectiveness is therapy with benzodiazepines and antipsychotics with the use of detoxification and general resuscitation measures. Most of the described cases of delirium resulted in complete recovery, deaths were associated with serotonin syndrome, suicides, accidents against the background excitement and acute somatic diseases with the underlying sympathicotonia.
- 30 June 2023
- Published by Ryazan State Medical University in Nauka Molodykh (Eruditio Juvenium)
- Vol. 11 (2)
Analysis of Symptoms, Approaches to Therapy and Outcomes of Synthetic Cathinone-Induced Delirium: Systematic Review
INTRODUCTION: One of the important disorders that can be induced by using synthetic cathinones (SC) is delirium, differentiated from other psychotic complications in ICD-11. The article presents a systematic review of the literature with the aim to describe the symptoms, the effectiveness of empirical approaches to therapy and probable outcomes of delirium induced by SC. The analysis of scientific publications in eLibrary, CNKI, PubMed, Scopus databases was performed using search by keywords. In accordance with the recommendations of PRISMA, 23 articles were selected. CONCLUSION: Most of the articles found were about MDPV-induced delirium. No exact dose range of SC that can cause delirium is specified. Delirium is more often described after prolonged use of SC (for 1 month), in more rare cases after a single use. In most cases delirium develops within a few hours after intake of SC and is associated with intoxication, rather than with withdrawal syndrome. The clinical picture of the studied conditions, besides the triad of the main symptoms of delirium, includes psychomotor excitement with pronounced sympathicotonia, in the vast majority of cases psychotic symptoms (acute sensory delirium with paranoid syndrome, true visual hallucinations, insomnia, aggressiveness expressed in the form of hetero- or autoaggression) are also present. Of highest effectiveness is therapy with benzodiazepines and antipsychotics with the use of detoxification and general resuscitation measures. Most of the described cases of delirium resulted in complete recovery, deaths were associated with serotonin syndrome, suicides, accidents against the background excitement and acute somatic diseases with the underlying sympathicotonia.
- 30 April 2023
- Published by LLC M-Center in Суицидология
- Vol. 14 (01(50)) , 101-114
Аутоагрессивные характеристики юношей и девушек, испытывающих отчётливые переживания стыда собственного тела
- 30 April 2023
- Published by LLC M-Center in Суицидология
- Vol. 14 (01(50)) , 101-114
Аутоагрессивные характеристики юношей и девушек, испытывающих отчётливые переживания стыда собственного тела
- 1 January 2021
- Published by LLC M-Center in Суицидология
- Vol. 12 (1) , 126-136
SUICIDOLOGICAL CHARACTERISTICS OF YOUNG MALES AND FEMALES PRACTICING UNPROTECTED SEXUAL CONTACTS WITH UNFAMILIAR PARTNERS
- 1 January 2021
- Published by LLC M-Center in Суицидология
- Vol. 12 (1) , 126-136
SUICIDOLOGICAL CHARACTERISTICS OF YOUNG MALES AND FEMALES PRACTICING UNPROTECTED SEXUAL CONTACTS WITH UNFAMILIAR PARTNERS
- 30 October 2017
- Published by Springer Nature in Neuroscience and Behavioral Physiology
- Vol. 47 (8) , 900-903
Systematics and Characteristics of the Development of Mental Disorders in Patients with HIV Infection
- 30 October 2017
- Published by Springer Nature in Neuroscience and Behavioral Physiology
- Vol. 47 (8) , 900-903
Systematics and Characteristics of the Development of Mental Disorders in Patients with HIV Infection